Texas Top Legal Officer Takes Legal Action Against Acetaminophen Manufacturers Over Autism Spectrum Claims

Courtroom Proceedings
The Texas Attorney General, a Trump ally campaigning for the United States Senate, claimed pharmaceutical manufacturers of withholding potential dangers of Tylenol

The top legal official in Texas Paxton is suing the makers of Tylenol, alleging the firms withheld alleged dangers that the medication created to pediatric brain development.

The court filing follows four weeks after Former President Trump promoted an unverified association between using Tylenol - also known as acetaminophen - while pregnant and autism in young ones.

Paxton is taking legal action against the pharmaceutical giant, which previously sold the drug, the exclusive pain medication recommended for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he claimed they "misled consumers by profiting off of pain and promoting medication regardless of the dangers."

The company states there is lacking scientific proof connecting acetaminophen to autism.

"These companies deceived for years, deliberately risking millions to line their pockets," Paxton, a Republican, stated.

The manufacturer commented that it was "seriously troubled by the dissemination of inaccurate information on the reliability of paracetamol and the potential impact that could have on the welfare of US mothers and children."

On its official site, the company also stated it had "continuously evaluated the applicable studies and there is lacking reliable evidence that shows a proven link between using acetaminophen and autism."

Associations acting on behalf of doctors and health professionals share this view.

The leading OB-GYN organization has said paracetamol - the main ingredient in Tylenol - is a restricted selection for expectant mothers to treat pain and fever, which can pose serious health risks if not addressed.

"In multiple decades of studies on the utilization of acetaminophen in gestation, not a single reputable study has conclusively proven that the usage of acetaminophen in any period of gestation causes neurological conditions in young ones," the organization said.

The lawsuit cites current declarations from the Trump administration in claiming the drug is potentially dangerous.

Last month, the former president generated worry from public health officials when he told pregnant women to "fight like hell" not to take Tylenol when ill.

Federal regulators then issued a notice that physicians should consider limiting the consumption of Tylenol, while also stating that "a causal relationship" between the drug and autism spectrum disorder in children has not been established.

The Health Department head RFK Jr, who manages the Food and Drug Administration, had promised in April to initiate "a massive testing and research effort" that would determine the source of autism spectrum disorder in a matter of months.

But specialists cautioned that discovering a unique factor of autism spectrum disorder - believed by scientists to be the result of a complex mix of genetic and environmental factors - would prove challenging.

Autism spectrum disorder is a type of permanent neurological difference and impairment that impacts how people perceive and interact with the world, and is recognized using medical professional evaluations.

In his court filing, Paxton - aligned with the former president who is seeking the Senate - asserts the manufacturer and J&J "deliberately disregarded and sought to suppress the research" around acetaminophen and autism spectrum disorder.

The lawsuit seeks to make the firms "remove any commercial messaging" that asserts Tylenol is secure for pregnant women.

This legal action echoes the complaints of a group of mothers and fathers of children with autism and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in two years ago.

Judicial authorities dismissed the legal action, saying research from the plaintiffs' authorities was inconclusive.

Joshua Walker
Joshua Walker

A tech enthusiast and writer passionate about innovation and digital culture.